Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 406483, 7 pages
http://dx.doi.org/10.1155/2013/406483
Clinical Study

Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis

1AOU “Maggiore della Carità,” 28100 Novara, Italy
2(Interdisciplinary Research Center of Autoimmune Diseases) IRCAD, Via Solaroli 17, 28100 Novara, Italy
3Department of Translational Medicine, “A. Avogadro” University, 28100 Novara, Italy

Received 29 January 2013; Revised 8 April 2013; Accepted 22 April 2013

Academic Editor: Carmen Guaza

Copyright © 2013 P. P. Sainaghi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Hafler, J. M. Slavik, D. E. Anderson, K. C. O'Connor, P. De Jager, and C. Baecher-Allan, “Multiple sclerosis,” Immunological Reviews, vol. 204, pp. 208–231, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Manfioletti, C. Brancolini, G. Avanzi, and C. Schneider, “The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade,” Molecular and Cellular Biology, vol. 13, no. 8, pp. 4976–4985, 1993. View at Google Scholar · View at Scopus
  3. P. J. Godowski, M. R. Mark, J. Chen, M. D. Sadick, H. Raab, and R. G. Hammonds, “Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3,” Cell, vol. 82, no. 3, pp. 355–358, 1995. View at Google Scholar · View at Scopus
  4. B. C. Varnum, C. Young, G. Elliot et al., “Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6,” Nature, vol. 373, no. 6515, pp. 623–626, 1995. View at Google Scholar · View at Scopus
  5. D. R. Joseph, “Sequence and functional relationships between androgen-binding protein/sex hormone-binding globulin and its homologs protein S, Gas6, laminin, and agrin,” Steroids, vol. 62, no. 8-9, pp. 578–588, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D. Binder and T. J. Kilpatrick, “TAM receptor signalling and demyelination,” NeuroSignals, vol. 17, no. 4, pp. 277–287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Lemke and Q. Lu, “Macrophage regulation by Tyro 3 family receptors,” Current Opinion in Immunology, vol. 15, no. 1, pp. 31–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Lu and G. Lemke, “Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family,” Science, vol. 293, no. 5528, pp. 306–311, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Alciato, P. P. Sainaghi, D. Sola, L. Castello, and G. C. Avanzi, “TNF-α, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages,” Journal of Leukocyte Biology, vol. 87, no. 5, pp. 869–875, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. L. Prieto, J. L. Weber, S. Tracy, M. J. Heeb, and C. Lai, “Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system,” Brain Research, vol. 816, no. 2, pp. 646–661, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Funakoshi, T. Yonemasu, T. Nakano, K. Matumoto, and T. Nakamura, “Identification of Gas6, a putative ligand for Sky and Axl receptor tyrosine kinases, as a novel neurotrophic factor for hippocampal neurons,” Journal of Neuroscience Research, vol. 68, no. 2, pp. 150–160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Prieto, S. O'Dell, B. Varnum, and C. Lai, “Localization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons,” Neuroscience, vol. 150, no. 2, pp. 319–334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Yagami, K. Ueda, K. Asakura et al., “Gas6 rescues cortical neurons from amyloid β protein-induced apoptosis,” Neuropharmacology, vol. 43, no. 8, pp. 1289–1296, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. R. H. Li, J. Chen, G. Hammonds et al., “Identification of Gas6 as a growth factor for human Schwann cells,” Journal of Neuroscience, vol. 16, no. 6, pp. 2012–2019, 1996. View at Google Scholar · View at Scopus
  15. S. L. Shankar, K. O'Guin, M. Cammer et al., “The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway,” Journal of Neuroscience, vol. 23, no. 10, pp. 4208–4218, 2003. View at Google Scholar · View at Scopus
  16. S. L. Shankar, K. O'Guin, M. Kim et al., “Gas6/Axl signaling activates the phosphatidylinositol 3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factorα-induced apoptosis,” Journal of Neuroscience, vol. 26, no. 21, pp. 5638–5648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. D. Binder, J. Xiao, D. Kemper, G. Z. M. Ma, S. S. Murray, and T. J. Kilpatrick, “Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination,” PLoS ONE, vol. 6, no. 3, article e17727, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Tsiperson, X. Li, G. J. Schwartz, C. S. Raine, and B. Shafit-Zagardo, “GAS6 enhances repair following cuprizone-induced demyelination,” PLoS ONE, vol. 5, no. 12, article e15748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Miller, F. Barkhof, X. Montalban, A. Thompson, and M. Filippi, “Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis,” Lancet Neurology, vol. 4, no. 5, pp. 281–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. W. I. McDonald, A. Compston, G. Edan et al., “Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis,” Annals of Neurology, vol. 50, no. 1, pp. 121–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. G. A. Schumacker, G. Beebe, R. F. Kibler et al., “Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis,” Annals of the New York Academy of Sciences, vol. 122, pp. 552–568, 1965. View at Google Scholar · View at Scopus
  22. M. A. Leone, S. Bonissoni, L. Collimedaglia et al., “Factors predicting incomplete recovery from relapses in multiple sclerosis: A Prospective Study,” Multiple Sclerosis, vol. 14, no. 4, pp. 485–493, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at Google Scholar · View at Scopus
  24. F. Alciato, P. P. Sainaghi, L. Castello, L. Bergamasco, S. Carnieletto, and G. C. Avanzi, “Development and validation of an ELISA method for detection of Growth Arrest Specific 6 (GAS6) protein in human plasma,” Journal of Immunoassay and Immunochemistry, vol. 29, no. 2, pp. 167–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. P. P. Sainaghi, F. Alciato, S. Carnieletto et al., “Gas6 evaluation in patients with acute dyspnea due to suspected pulmonary embolism,” Respiratory Medicine, vol. 103, no. 4, pp. 589–594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. P. P. Sainaghi, L. Collimedaglia, F. Alciato et al., “Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP),” Journal of the Neurological Sciences, vol. 269, no. 1-2, pp. 138–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. G. Weinger, K. M. Omari, K. Marsden, C. S. Raine, and B. Shafit-Zagardo, “Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions,” American Journal of Pathology, vol. 175, no. 1, pp. 283–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. H. Shao, Y. Zhen, R. A. Eisenberg, and P. L. Cohen, “The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells,” Clinical Immunology, vol. 133, no. 1, pp. 138–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Grommes, C. Y. D. Lee, B. L. Wilkinson et al., “Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases,” Journal of NeuroImmune Pharmacology, vol. 3, no. 2, pp. 130–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Sen, M. A. Wallet, Z. Yi et al., “Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-κB activation in dendritic cells,” Blood, vol. 109, no. 2, pp. 653–660, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. P. Sainaghi, L. Castello, L. Bergamasco, M. Galletti, P. Bellosta, and G. C. Avanzi, “Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor,” Journal of Cellular Physiology, vol. 204, no. 1, pp. 36–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. P. P. Sainaghi, L. Collimedaglia, F. Alciato et al., “The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy,” Cytokine, vol. 51, no. 2, pp. 138–143, 2010. View at Publisher · View at Google Scholar · View at Scopus